 |
|
If you need to get a quote for any product, or have any questions, please fill in the
following contact form, we will contact you within 24 hours. If your have an account with us, click here to login to retrieve your information.
| Your Contact Information (Required *) |
| First Name* |
|
| Last Name* |
|
| E-Mail* |
|
| Company Name* |
|
| Address |
|
| City |
|
| State |
|
| Zip |
|
| Country |
|
| Phone |
|
| Fax |
|
| Web Site |
|
| |
| Products Interested (Browsing products) |
|
| Product ID |
CAS Number |
Product Name |
Quantity |
| A1-0006 |
150349-36-3 |
N-(4-Aminopropyl)-N-methyl carbamic acid tert-butyl ester |
|
| A1-0151 |
444666-46-0 |
N-1-CBZ-2-Methylpiperazine |
|
| A1-0287 |
19125-34-9 |
1-N-Phenylpiperidin-4-one |
|
| A1-4385 |
350-31-2 |
4-CHLORO-3-FLUORONITROBENZENE |
|
| AS-3256 |
137218-25-8 |
2-Triflnoromethoxybenzyl cyanide |
|
| AS-3470 |
131341-86-1 |
FLUDIOXONIL |
|
| AS-3724 |
112811-66-2 |
2,4,5-Trifluoro-3-methoxybenzoyl chloride |
|
| AS-3972 |
16937-99-8 |
BOC-D-Leucine monohydrate |
|
| JR6-L3139 |
75714-59-9 |
1,1'-Binaphthalene, 3,3'-dibromo-2,2'-dimethoxy-, (1R)- |
|
| JR6-L3173 |
870755-10-5 |
[1,1'-Binaphthalene]-2,2'-diol, 3-[[(1R)-2-hydroxy-2'-methoxy[1,1'-binaphthalen]-3-yl]methyl]-, (1R)- (9CI) |
|
| JR6-L3622 |
1217609-84-1 |
1H-Thieno[3,4-d]imidazole-4-pentanamide, hexahydro-N-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethyl]-2-oxo-, (3aR,4R,6aS)-rel- |
|
| JR6-L5780 |
1165450-70-3 |
2-Pyrrolidinone, 4-(hydroxymethyl)-, (4R)- |
|
| JR6-L6179 |
847456-64-8 |
Benzenesulfonamide, 4-[[(9,10-dihydro-9-oxo-4-acridinyl)methyl]amino]-N-(3,4-dimethyl-5-isoxazolyl)- |
|
| JR6-L6233 |
303111-43-5 |
3-Pyrrolidinemethanol, 1-(phenylmethyl)-, (3R)- |
|
| JR6-L6438 |
1309873-83-3 |
Propanoic acid, 2,2-dimethyl-3-oxo-3-[[[1-(triphenylmethyl)-1H-imidazol-4-yl]methyl]amino]- |
|
| JR6-L6464 |
87736-89-8 |
Benzoic acid, 4-[3-(trifluoromethyl)-3H-diazirin-3-yl]-, 2,5-dioxo-1-pyrrolidinyl ester |
|
| JR6-L6807 |
854678-20-9 |
1H-Pyrazol-5-ol, 1-(4-bromo-2-fluorophenyl)-3-(trifluoromethyl)- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Comments |
| |
|
 |
|
|
|
|
|
|